Companion Diagnostics for Oncology market to surpass USD 8.45 billion by 2030 from USD 2.48 billion in 2020 at a CAGR of 13.02% in the coming years, i.e., 2021-30.
Product Overview
Companion diagnostics is a medical equipment, usually an in-vitro device,…
The global liposomal doxorubicin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously trackin…
The global acute myeloid leukemia therapeutics market grew at a CAGR of around 7% during 2015-2020. Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It primarily impacts the bone marrow and white bl…
Market Overview
Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Sev…